Compare VNCE & LGVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VNCE | LGVN |
|---|---|---|
| Founded | 2002 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Clothing/Shoe/Accessory Stores | Medicinal Chemicals and Botanical Products |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 30.9M | 34.0M |
| IPO Year | 2013 | 2021 |
| Metric | VNCE | LGVN |
|---|---|---|
| Price | $4.83 | $0.89 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 1 |
| Target Price | ★ $5.17 | $3.00 |
| AVG Volume (30 Days) | 245.2K | ★ 825.0K |
| Earning Date | 04-15-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 132.45 | 50.76 |
| EPS | ★ 0.49 | N/A |
| Revenue | ★ $300,007,000.00 | $709,000.00 |
| Revenue This Year | $5.86 | N/A |
| Revenue Next Year | N/A | $10.81 |
| P/E Ratio | $9.48 | ★ N/A |
| Revenue Growth | ★ 2.23 | N/A |
| 52 Week Low | $1.19 | $0.48 |
| 52 Week High | $5.28 | $1.80 |
| Indicator | VNCE | LGVN |
|---|---|---|
| Relative Strength Index (RSI) | 74.74 | 40.63 |
| Support Level | $2.41 | $0.74 |
| Resistance Level | N/A | $0.99 |
| Average True Range (ATR) | 0.48 | 0.08 |
| MACD | 0.20 | -0.04 |
| Stochastic Oscillator | 85.34 | 2.61 |
Vince Holding Corp is a fashion brand that is engaged in wholesale and retail delivery of luxury essentials like women's and men's apparel, women's and men's footwear, and handbags. Its offers women's collections of luxurious cashmere sweaters and silk blouses, leather and suede leggings and jackets, dresses, denim, pants, tanks and t-shirts, and a growing assortment of outerwear. It focuses on developing an elevated collection of Vince apparel and accessories to serve the luxurious need of the customer. The company manages its business in three segments namely Vince Wholesale, Vince Direct-to-consumer, and Rebecca Taylor and Parker segment. It operates its e-commerce business through its website. Majority of its revenue generated from Vince Wholesale segment.
Longeveron Inc is a clinical stage biotechnology company developing regenerative medicines to address unmet medical needs. Its investigational product candidate is laromestrocel. Laromestrocel is a proprietary, scalable, allogeneic cellular therapy that has multiple potential modes of action that include pro-vascular, pro-regenerative, and anti-inflammatory mechanisms that collectively appear to promote tissue repair and healing. It is in clinical development of a single investigational product candidate, laromestrocel, for four potential indications: HLHS, Alzheimer's disease (AD), Pediatric Dilated Cardiomyopathy (pediatric DCM), and Aging-related Frailty. It operates in a single operating segment focused on developing regenerative medicines to address unmet medical needs.